CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2005-06-08 | FAHIM RAAFAT E F Sr. VP Tech. & Prod. | Purchase | +2,000 | $12.15 | $24K | 5,630.68 |
| 2005-05-31 | SMITH MARK L Sr. VP Fin., CFO, CAO & Treas. | Other acquisition | +1,228.44 | $10.58 | $13K | 19,908.23 |
| 2005-05-31 | RASMUSSEN HENRIK S MD Sr. VP Clin. Med. & Reg. Affs. | Other acquisition | +921.33 | $10.58 | $10K | 1,876.35 |
| 2005-05-31 | MCLAIN THOMAS H Chairman, CEO & President | Other acquisition | +1,228.44 | $10.58 | $13K | 48,776.25 |
| 2005-05-31 | FAHIM RAAFAT E F Sr. VP Tech. & Prod. | Other acquisition | +1,228.44 | $10.58 | $13K | 6,859.12 |
| 2005-05-27 | COX GEOFFREY F Director | Exercise or conversion | +7,500 | $3.25 | $24K | 20,479 |
| 2005-05-27 | COX GEOFFREY F Director | Shares withheld for taxes | −1,958 | $12.45 | $24K | 18,521 |
| 2005-05-27 | COX GEOFFREY F Director | Exercise or conversion · Stock Option (right to buy) | −7,500 | 0 | ||
| 2005-05-26 | HARVEY RICHARD A JR Director | Exercise or conversion | +4,500 | $4.88 | $22K | 23,496 |
| 2005-05-26 | HARVEY RICHARD A JR Director | Exercise or conversion · Stock Option (right to buy) | −4,500 | 0 |
Page 42 of 42 · 830 trades